Urges United States Supreme Court to protect freedom of reproductive choice with respect to use of and access to mifepristone.
New Jersey Senate Resolution 78, introduced by Senator Linda Greenstein, urges the U.S. Supreme Court to resolve conflicting federal court rulings about mifepristone - a medication approved by the FDA for medical abortions and reproductive health care - and to protect access to it without undue government interference. The resolution emphasizes mifepristone’s safety (deemed safer than common drugs like penicillin) and its critical role in reproductive health, noting that 40 million women could lose access if current legal disputes persist. It calls on the Court to prioritize medical expertise, public health, and individuals’ freedom to make private reproductive health decisions. This non-binding resolution does not change laws but formally expresses New Jersey’s position to the Supreme Court and federal lawmakers.
Bill status
in committee
1 of 4 stages cleared
Introduction
Mar 2024
Committee Review
Floor Vote
Governor
Introduced Mar 4, 2024
Last action Mar 4, 2024
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
1
Key actions
0
Committee
0
Mar 4, 2024
Introduced
Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee
upper
1 primary · 0 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Linda Greenstein
DDemocratic
Ask Maddy
·
AI policy assistant
Ask Maddy about SR 78
Scope: NJ
Hi! I can help you understand SR 78. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline